A detailed history of Everpar Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Everpar Advisors LLC holds 2,815 shares of ABT stock, worth $317,081. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,815
Previous 2,822 0.25%
Holding current value
$317,081
Previous $321 Million 8.81%
% of portfolio
0.15%
Previous 0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$100.73 - $112.44 $705 - $787
-7 Reduced 0.25%
2,815 $293 Million
Q1 2024

Apr 22, 2024

SELL
$109.52 - $120.96 $162,308 - $179,262
-1,482 Reduced 34.43%
2,822 $321 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $388,177 - $475,161
4,304 New
4,304 $474 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Everpar Advisors LLC Portfolio

Follow Everpar Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everpar Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Everpar Advisors LLC with notifications on news.